Molecular Evidence for Decreased Synaptic Efficacy in the Postmortem Olfactory Bulb of Individuals with Schizophrenia

Overview

Journal Schizophr Res

Specialty Psychiatry

Date 2015 Aug 12

PMID 26260078

Citations 10

Authors

Chijioke N Egbujo

Duncan Sinclair

Karin E Borgmann-Winter

Steven E Arnold

Bruce I Turetsky

Chang-Gyu Hahn

Affiliations

Soon will be listed here.

Abstract

Multiple lines of evidence suggest altered synaptic plasticity/connectivity as a pathophysiologic mechanism for various symptom domains of schizophrenia. Olfactory dysfunction, an endophenotype of schizophrenia, reflects altered activity of the olfactory circuitry, which conveys signals from olfactory receptor neurons to the olfactory cortex via synaptic connections in the glomeruli of the olfactory bulb. The olfactory system begins with intranasal olfactory receptor neuron axons synapsing with mitral and tufted cells in the glomeruli of the olfactory bulb, which then convey signals directly to the olfactory cortex. We hypothesized that olfactory dysfunction in schizophrenia is associated with dysregulation of synaptic efficacy in the glomeruli of the olfactory bulb. To test this, we employed semi-quantitative immunohistochemistry to examine the olfactory bulbs of 13 postmortem samples from schizophrenia and their matched control pairs for glomerular expression of 5 pre- and postsynaptic proteins that are involved in the integrity and function of synapses. In the glomeruli of schizophrenia cases compared to their matched controls, we found significant decreases in three presynaptic proteins which play crucial roles in vesicular glutamate transport - synapsin IIa (-18.05%, p=0.019), synaptophysin (-24.08% p=0.0016) and SNAP-25 (-23.9%, p=0.046). Two postsynaptic proteins important for spine formation and glutamatergic signaling were also decreased-spinophilin (-17.40%, p=0.042) and PSD-95 (-34.06%, p=0.015). These findings provide molecular evidence for decreased efficacy of synapses within the olfactory bulb, which may represent a synaptic mechanism underlying olfactory dysfunction in schizophrenia.

Citing Articles

Specific neuroblast-derived signals control both cell migration and fate in the rostral migratory stream.

Zhou W, Munoz J, Henry Ho H, Hanamura K, Dalva M bioRxiv. 2025; .

PMID: 40027825 PMC: 11870606. DOI: 10.1101/2025.02.18.638163.

Chronic exposure to MK-801 leads to olfactory deficits and reduced neurogenesis in the olfactory bulbs of adult male mice.

Sinegubov A, Dyachuk V Front Behav Neurosci. 2024; 18:1441910.

PMID: 39301433 PMC: 11410574. DOI: 10.3389/fnbeh.2024.1441910.

Viral Infections and Schizophrenia: A Comprehensive Review.

Kotsiri I, Resta P, Spyrantis A, Panotopoulos C, Chaniotis D, Beloukas A Viruses. 2023; 15(6).

PMID: 37376644 PMC: 10302918. DOI: 10.3390/v15061345.

Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity.

Wu X, Shukla R, Alganem K, Zhang X, Eby H, Devine E Mol Psychiatry. 2021; 26(12):7699-7708.

PMID: 34272489 PMC: 8761210. DOI: 10.1038/s41380-021-01205-y.

Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies.

Berdenis van Berlekom A, Muflihah C, Snijders G, MacGillavry H, Middeldorp J, Hol E Schizophr Bull. 2019; 46(2):374-386.

PMID: 31192350 PMC: 7442385. DOI: 10.1093/schbul/sbz060.

References

Kamath V, Moberg P, Kohler C, Gur R, Turetsky B . Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients. Schizophr Bull. 2011; 39(1):59-67. PMC: 3523921. DOI: 10.1093/schbul/sbr050. View

Rosoklija G, Toomayan G, Ellis S, Keilp J, Mann J, Latov N . Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry. 2000; 57(4):349-56. DOI: 10.1001/archpsyc.57.4.349. View

Woods S . Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003; 64(6):663-7. DOI: 10.4088/jcp.v64n0607. View

Arnold S, Han L, Moberg P, Turetsky B, Gur R, Trojanowski J . Dysregulation of olfactory receptor neuron lineage in schizophrenia. Arch Gen Psychiatry. 2001; 58(9):829-35. DOI: 10.1001/archpsyc.58.9.829. View

Ide M, Lewis D . Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits. Biol Psychiatry. 2010; 68(1):25-32. PMC: 2900524. DOI: 10.1016/j.biopsych.2010.02.016. View

Gitler D, Cheng Q, Greengard P, Augustine G . Synapsin IIa controls the reserve pool of glutamatergic synaptic vesicles. J Neurosci. 2008; 28(43):10835-43. PMC: 2605971. DOI: 10.1523/JNEUROSCI.0924-08.2008. View

Thompson P, Sower A, Perrone-Bizzozero N . Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry. 1998; 43(4):239-43. DOI: 10.1016/S0006-3223(97)00204-7. View

Kirov G, Pocklington A, Holmans P, Ivanov D, Ikeda M, Ruderfer D . De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry. 2011; 17(2):142-53. PMC: 3603134. DOI: 10.1038/mp.2011.154. View

Talbot K, Eidem W, Tinsley C, Benson M, Thompson E, Smith R . Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest. 2004; 113(9):1353-63. PMC: 398430. DOI: 10.1172/JCI20425. View

10.

Vawter M, Howard A, Hyde T, Kleinman J, Freed W . Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia. Mol Psychiatry. 1999; 4(5):467-75. DOI: 10.1038/sj.mp.4000547. View

11.

Moberg P, Kamath V, Marchetto D, Calkins M, Doty R, Hahn C . Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophr Bull. 2013; 40(1):50-9. PMC: 3885295. DOI: 10.1093/schbul/sbt049. View

12.

Amad A, Cachia A, Gorwood P, Pins D, Delmaire C, Rolland B . The multimodal connectivity of the hippocampal complex in auditory and visual hallucinations. Mol Psychiatry. 2013; 19(2):184-91. DOI: 10.1038/mp.2012.181. View

13.

Genzel L, Dresler M, Cornu M, Jager E, Konrad B, Adamczyk M . Medial prefrontal-hippocampal connectivity and motor memory consolidation in depression and schizophrenia. Biol Psychiatry. 2014; 77(2):177-86. DOI: 10.1016/j.biopsych.2014.06.004. View

14.

Talbot K, Wang H, Kazi H, Han L, Bakshi K, Stucky A . Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012; 122(4):1316-38. PMC: 3314463. DOI: 10.1172/JCI59903. View

15.

Varea E, Guirado R, Gilabert-Juan J, Marti U, Castillo-Gomez E, Blasco-Ibanez J . Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients. J Psychiatr Res. 2011; 46(2):189-97. DOI: 10.1016/j.jpsychires.2011.10.011. View

16.

Karson C, Mrak R, Schluterman K, STURNER W, Sheng J, Griffin W . Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Mol Psychiatry. 1999; 4(1):39-45. DOI: 10.1038/sj.mp.4000459. View

17.

Funk A, Rumbaugh G, Harotunian V, McCullumsmith R, Meador-Woodruff J . Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia. Neuroreport. 2009; 20(11):1019-22. PMC: 3731946. DOI: 10.1097/WNR.0b013e32832d30d9. View

18.

Turetsky B, Hahn C, Borgmann-Winter K, Moberg P . Scents and nonsense: olfactory dysfunction in schizophrenia. Schizophr Bull. 2009; 35(6):1117-31. PMC: 2762633. DOI: 10.1093/schbul/sbp111. View

19.

. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511(7510):421-7. PMC: 4112379. DOI: 10.1038/nature13595. View

20.

Eastwood S, Burnet P, Harrison P . Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience. 1995; 66(2):309-19. DOI: 10.1016/0306-4522(94)00586-t. View